Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib + Capecitabine in Metastatic Pancreatic Cancer
NCT01423604Phase 2Completed
- Sponsor
- Incyte
- Start
- Jul 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ruxolitinib, sponsored by Incyte. Started Jul 2011; status: completed.
02
Drugs
Beyond the preview
Go deeper on NCT01423604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01423604.